Shenu AgarwalDheeraj HindujaAlkem LaboratoriesCholamandalam Financial HoldingsPage Industries3M IndiaNatco PharmaBharat DynamicsMax HealthcareJaguar Land RoverAshok Leyland

Bharat Dynamics Q1 net profit jumps multifold to ₹119 crore; Alkem Labs profit falls 21% to ₹520 crore as Indian companies report mixed earnings

Bharat Dynamics reported a remarkable Q1 net profit of ₹119 crore, a significant increase from ₹18.3 crore a year earlier, while Alkem Laboratories saw a 21.7% decline in net profit to ₹520 crore despite a revenue rise of 10.9% to ₹3,740 crore, reflecting mixed earnings among Indian firms.

NDTV Profit+1 source14 August 2026 · 09:19 UTC
CuriousCats Full Story

Bharat Dynamics reported a net profit of ₹119 crore for Q1FY27, a substantial increase from ₹18.3 crore in the same quarter last year. The company's revenue surged to ₹572 crore, compared to ₹248 crore a year ago, with an EBITDA of ₹82.8 crore compared to a loss of ₹45.3 crore previously. The EBITDA margin improved to 14.5%.29

In contrast, Alkem Laboratories experienced a 21.7% drop in net profit, falling to ₹520 crore from ₹664 crore year-on-year. Despite this decline, the company reported a revenue increase of 10.9% to ₹3,740 crore, with an EBITDA rise of 3.7% to ₹766 crore. The EBITDA margin decreased to 20.5% from 21.9% in the previous year, and tax expenses rose significantly to ₹251 crore from ₹103 crore.1

These results highlight the mixed performance of Indian companies in the current earnings season, with Bharat Dynamics showcasing strong growth while Alkem Laboratories grapples with profitability challenges amidst rising costs and competitive pressures.

Key Insight
“Natco Pharma's PAT plunged 84% to ₹74.6 crore, with shares falling over 6% to ₹893 on the NSE. Ashok Leyland's PAT rose 2.5% y-o-y but dropped 56.6% sequentially, while its CEO cited robust demand and cost-saving initiatives.”
CuriousCats studied:
1
NDTV Profit
Alkem Laboratories Q1 Results - Cons, YoY - Net profit down 21.7% at Rs 520 crore vs Rs 664 crore YoY - Revenue up 10.9% at Rs 3,740 crore vs Rs 3,371 crore YoY - EBITDA up 3.7% at Rs 766 crore vs Rs 739 crore YoY - EBITDA margin at 20.5% vs 21.9% YoY - Tax expense at Rs 251 crore vs Rs 103 crore YoY”
NDTV Profit →
2
thehindubusinessline.comthehindubusinessline.com
“Ashok Leyland: Standalone PAT of ₹609.11 crore in Q1FY27”
thehindubusinessline.com →
Ask CuriousCats
What caused Natco Pharma's profit drop?
How did Bharat Dynamics perform in Q1?
Why did Ashok Leyland's profit decline sequentially?
Are other Indian companies experiencing mixed earnings?
Which firms reported profit increases this quarter?
Get your CIA-level briefing,
in real time.
CuriousCats monitors the internet every minute for you and brings you the most personalized brief of videos, social media posts, news and more.
Download the App
One story brought you here.
CuriousCats brings you everything else worth knowing.
Get CuriousCats